Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States-Reference-Cited by-同舟云学术

Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States

Published:2013-02-21 Issue:10 Volume:119 Page:1916-1923
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kavcic Marko,Fisher Brian T.,Li Yimei,Seif Alix E.,Torp Kari,Walker Dana M.,Huang Yuan-Shung,Lee Grace E.,Tasian Sarah K.,Vujkovic Marijana,Bagatell Rochelle,Aplenc Richard

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Pediatric acute myeloid leukemia: international progress and future directions;Kaspers;Leukemia.,2005

2. Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group;Lange;Blood.,2008

3. AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group;Cooper;Cancer.,2012

4. United Kingdom Childhood Leukaemia Working Group and the Dutch Childhood Oncology Group. Results of a randomized trial in children with acute myeloid leukaemia: Medical Research Council AML12 trial;Gibson;Br J Haematol.,2011

5. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group;Woods;Blood.,1996

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of acute leukemia complications in children at the disease onset and during induction;Oncohematology;2023-12-08

2. Fungal diagnostic testing and therapy: navigating the neutropenic period in children with high-risk leukemia;Hematology;2021-12-10

3. Analysis of efficacy, safety and prognostic factors of DAC‑HAA treatment in Chinese pediatric patients with refractory or relapsed acute myeloid leukemia;Molecular and Clinical Oncology;2021-11-01

4. Outcomes of intensification of induction chemotherapy for children with high‐risk acute myeloid leukemia: A report from the Children's Oncology Group;Pediatric Blood & Cancer;2021-10

5. Cytarabine dose reduction in patients with low‐risk acute myeloid leukemia: A report from the Children's Oncology Group;Pediatric Blood & Cancer;2021-09-02